Bank of New York Mellon
XTNT icon

Bank of New York Mellon’s Xtant Medical Holdings XTNT Stock Holding History

Bank of New York Mellon’s Portfolio XTNT Stock Details XTNT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-890
Closed -$7K – 4351
2017
Q1 		$7K Buy
+890
New +$5.47K ﹤0.01% 4264

Other funds holding XTNT

PCM
Perkins Capital Management Wayzata, Minnesota $133M AUM 127.86% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
VKH
Virtu KCG Holdings New York $3.6B AUM 19.31% 1-Year Est. Return
OA
Outfitter Advisors Mclean, Virginia $221M AUM 13.61% 1-Year Est. Return
GCM
Goldman Capital Management New York $103M AUM 21.37% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
California Public Employees Retirement System
California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return
Northwestern Mutual Wealth Management
Northwestern Mutual Wealth Management Milwaukee, Wisconsin $162B AUM 16.35% 1-Year Est. Return
WEC
Winslow Evans & Crocker Boston, Massachusetts $528M AUM 30.99% 1-Year Est. Return

Bank of New York Mellon's XTNT Position: Q2 2017 in Review

Bank of New York Mellon sold out of Xtant Medical Holdings (XTNT) in Q2 2017, closing a stake of 890 shares — an estimated $7K sold.

Bank of New York Mellon first reported a position in XTNT in Q1 2017 and held it in 1 quarter. The position peaked at $7K in Q1 2017. 17 funds tracked by Wall St. Rank hold XTNT as of Q2 2017.

  • Bank of New York Mellon reported no remaining Xtant Medical Holdings position as of Q2 2017 after selling out during the quarter.
  • Bank of New York Mellon sold 890 Xtant Medical Holdings shares in Q2 2017, an estimated $7K.
  • Bank of New York Mellon first reported a position in Xtant Medical Holdings in Q1 2017 and held it in 1 quarter.
  • Bank of New York Mellon's Xtant Medical Holdings position peaked at $7K in Q1 2017.
  • 17 funds tracked by Wall St. Rank held Xtant Medical Holdings as of Q2 2017.

Based on Bank of New York Mellon's 13F filing for Q2 2017, filed 3 Aug 2017.